
Also known as Sema
Long-acting GLP-1 receptor analogue — 10mg, 20mg and 30mg lyophilised vials at 99%+ purity for in vitro incretin and receptor-binding research.
Best value and fastest option — supplied as a lyophilised vial, shipped the same day when ordered by 1pm, Monday to Friday.
For In Vitro Use Only — Not for Human Use
Factory independent testing is reviewed for every batch, and we go the extra mile with our own independent HPLC & mass-spec testing in Europe. Where our certificate has been published, it is batch-numbered so you can match it to your vial.
Semaglutide is a long-acting 31-residue GLP-1 receptor analogue with a C18 fatty-diacid modification at Lys26 that extends its plasma half-life relative to native GLP-1. Supplied as a 30mg sterile lyophilised powder, verified to 99%+ purity by RP-HPLC and confirmed by mass spectrometry.
Semaglutide is a reference GLP-1 agonist in in vitro receptor pharmacology — used to characterise cAMP response, β-arrestin recruitment, receptor internalisation and comparator responses when benchmarking dual (Tirzepatide) and triple (Retatrutide) agonists.